These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells. Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Götz M, Döhner H, Bunjes D, Schmitt M. Br J Haematol; 2009 Jan; 144(2):195-205. PubMed ID: 19016717 [Abstract] [Full Text] [Related]
4. Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo. Fraser CK, Blake SJ, Diener KR, Lyons AB, Brown MP, Hughes TP, Hayball JD. Exp Hematol; 2009 Feb; 37(2):256-65. PubMed ID: 19056158 [Abstract] [Full Text] [Related]
5. Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study. Uchiyama T, Sato N, Narita M, Yamahira A, Iwabuchi M, Furukawa T, Sone H, Takahashi M. Hematol Oncol; 2013 Sep; 31(3):156-63. PubMed ID: 23108877 [Abstract] [Full Text] [Related]
6. The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation. Chen J, Schmitt A, Bunjes D, Chen B, Schmitt M. Int J Oncol; 2007 May; 30(5):1119-27. PubMed ID: 17390013 [Abstract] [Full Text] [Related]
18. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Johnson FM, Saigal B, Talpaz M, Donato NJ. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6924-32. PubMed ID: 16203784 [Abstract] [Full Text] [Related]
19. Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha. Baumgartner C, Gleixner KV, Peter B, Ferenc V, Gruze A, Remsing Rix LL, Bennett KL, Samorapoompichit P, Lee FY, Pickl WF, Esterbauer H, Sillaber C, Superti-Furga G, Valent P. Exp Hematol; 2008 Oct 01; 36(10):1244-53. PubMed ID: 18619723 [Abstract] [Full Text] [Related]